Human sebaceous tumors harbor inactivating mutations in LEF1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Wnt signaling is crucial for development and often dysregulated in cancer.
• LEF1 is a key transcription factor in the Wnt pathway.
• Sebaceous tumors are neoplasms of sebaceous glands with poorly understood molecular underpinnings.

Purpose of the Study:

• To investigate the role of LEF1 mutations in human sebaceous tumors.
• To determine the functional consequences of identified LEF1 mutations.
• To explore the potential impact of mutant LEF1 on tumor characteristics.

Main Methods:

• Genomic analysis of human sebaceous tumors to identify mutations.
• Functional assays to assess LEF1 binding to beta-catenin.
• Reporter gene assays to measure transcriptional activation of Wnt target genes.
• Analysis of sebocyte marker expression in tumors with mutant LEF1.

Main Results:

• Double-nucleotide substitutions in the LEF1 gene were identified in one-third of examined human sebaceous tumors.
• These LEF1 mutations occurred independently of DNA mismatch repair status.
• Mutant LEF1 demonstrated impaired binding to beta-catenin and reduced transcriptional activation.
• Mutant LEF1 inhibited Wnt target gene expression and stimulated sebocyte marker expression.

Conclusions:

• The study identified the first tumor-associated mutations that inactivate Wnt signaling via LEF1.
• Mutant LEF1 may play a critical role in the pathogenesis of sebaceous tumors.
• Mutant LEF1 appears to influence the differentiated phenotype of sebaceous tumors, potentially driving their specific characteristics.